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AbstrAct
Background Antimicrobial resistance is an increasing 
problem in human and veterinary medicine and is closely 
linked to the use of antimicrobials. The objective of this 
study was to describe antimicrobial prescriptions for 
selected canine diseases in Switzerland during 2016.
Methods Dogs presented to two university hospitals 
and 14 private practices for acute diarrhoea (AD; n=371), 
suspected or confirmed urinary tract infections (UTIs; 
n=245), respiratory tract infections (RTIs; n=274) or wound 
infections (WIs; n=175) were included. Clinical history, 
diagnostic work- up and antimicrobial prescription (class, 
dosage and duration) were retrospectively assessed. A 
justification score was applied to evaluate appropriateness 
of antimicrobial therapy based on available national and 
international consensus guidelines.
Results Antimicrobials were prescribed in 65 per cent of 
dogs with AD, 88 per cent with UTI, 62 per cent with RTI 
and 90 per cent with WI. The most prescribed antimicrobial 
classes (monotherapy and combination therapy) were 
potentiated aminopenicillins (59 per cent), nitroimidazoles 
(22 per cent), non- potentiated aminopenicillins (16 per 
cent) and fluoroquinolones (13 per cent). Overall, 38 per 
cent (95 per cent CI 0.35 to 0.41) of the prescriptions were 
in accordance with consensus guidelines. In dogs with AD, 
antimicrobial therapy was associated with the presence 
of haemorrhagic diarrhoea (P<0.05) and complied in 32 
per cent with consensus guidelines, which recommend 
antimicrobial treatment only when sepsis is suspected. 
A bacterial aetiology was confirmed via culture and/
or sediment examination in 36 per cent of dogs with 
suspected UTI.
Conclusions Overall, adherence to consensus guidelines 
was poor both, at university hospitals and private 
practices. Antimicrobial stewardship measures are 
therefore needed to improve prudent use.
IntRoduCtIon
Antimicrobials are vital to modern medi-
cine, and antimicrobial resistance is a global, 
urgent threat to human and animal health. 
The development of antimicrobial resist-
ance is unambiguously linked to exposure of 
bacteria to antimicrobials.1 Dogs and cats are 
considered family members in many house-
holds and benefit from advanced medical 
care, which often includes hospitalisation and 
treatments with broad- acting antimicrobials, 
many of them being of critical importance 
to human medicine. The selection pressure 
put on bacterial populations via the adminis-
tration of antimicrobials favours the selection 
of multidrug- resistant organisms (MDROs) 
such as methicillin- resistant Staphylococcus 
pseudintermedius and extended- spectrum 
beta- lactamase producing Escherichia coli.2–5 
Small animal medicine therefore likely plays 
a significant role in the selection and dissem-
ination of MDROs. To foster the prudent 
use of antimicrobials, guidelines have been 
created in both human and veterinary medi-
cine.6–9
Antimicrobial prescribing habits by small 
animal veterinarians have been reported from 
a number of countries including the USA,10 
Australia,11 Belgium,12 UK,13 Finland,14 
Denmark15 and Italy.16 Such studies are 
either designed as surveys using fictional case 
scenarios,11–13 16 or based on data extracted 
from pharmacy or patient records.13 14 17–23 
Patterns of antimicrobial use for selected 
diseases in cats in Switzerland have recently 
been published.24 The results of these studies 
indicate that overprescription of antimicro-
bials including critically important antimi-
crobials and non- adherence to guidelines is 
common in small animal medicine but varies 
considerably between countries. In Europe, 
a north- to- south and a west- to- east gradient 
with lower percentages of resistant bacterial 
isolates reported in the north and west of 
Europe have been described.25 This phenom-
enon is partly linked to the existence and level 
of implementation of national antimicrobial 
stewardship strategies.7 8 In order to achieve 
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Table 1 Inclusion and exclusion criteria and search terms for the surveyed indications
Indication Included Excluded Search terms
Acute diarrhoea  ► Diarrhoea <3 weeks.
 ► Acute haemorrhagic 
diarrhoea syndrome 
(AHDS).
 ► Parasitic diarrhoea.
 ► Non- specific 
diarrhoea.
 ► Diarrhoea >3 weeks or relapsing.
 ► Diarrhoea related to drug 
administration or another 
extradigestive disease.
 ► Diarrhoea that appeared during 
hospitalisation.
 ► Parvovirosis.
Diarrhoea, colitis, duodenitis, enteritis, ileitis, 
gastritis, AHDS, haemorrhagic gastroenteritis and 
Giardia, watery stools.
Urinary tract 
infection
 ► Suspicion or 
diagnosis of 
bacterial cystitis.
 ► Suspicion or 
diagnosis of 
pyelonephritis.
 ► Glomerulonephritis.
 ► Leptospirosis.
 ► Urolithiasis without signs of 
bacteriuria.
Urinary tract infection, dysuria, difficult urination, 
stranguria, haematuria, bloody urine, blood 
in urine, polyuria, pollakiuria, pyelonephritis, 
inflammation of the bladder, cystitis, bladder and 
urinalysis.
Respiratory tract 
infection
 ► Aspiration 
pneumonia.
 ► Pneumonia 
(bacterial, viral and 
unknown).
 ► Bronchitis.
 ► Kennel cough.
 ► Nasal infections.
 ► Fungal infections.
 ► Neoplasia of the respiratory tract.
 ► Lung worms.
Respiratory tract infection, respiratory tract 
disease, cough, tracheitis, tracheobronchitis, 
pneumonia, inflammation of the lungs, bronchitis, 
bronchopneumonia, kennel cough, distemper, 
influenza, adenovirus, dyspnoea and tachypnoea.
Wound infection  ► Bite wound.
 ► Abscess.
 ► Anal gland abscess.
 ► Dental abscess.
 ► Abscess due to a foreign body.
 ► Hotspot.
Wound infection, abscess, purulent wound and 
bite.
the highest possible impact of prudent use guidelines, 
current prescribing behaviours as well as the regional 
availability of specific antibiotics need to be taken into 
consideration. It is therefore crucial to perform studies 
at a national as well as international level.
In 2015, the Swiss National Strategy on Antibiotic 
resistance was passed by the federal council. As part of 
its implementation, an online tool ( AntibioticScout. ch) 
assisting veterinarians in the selection of prudent empir-
ical antimicrobial therapy was created. This tool became 
available to veterinarians in December 2016.26 27
The aim of this study was to assess antimicrobial use 
in small animal medicine in Switzerland in 2016, before 
introduction of the antimicrobial stewardship tool  Anti-
bioticScout. ch. Four conditions in dogs for which anti-
microbials are frequently prescribed, including acute 
diarrhoea (AD), urinary tract infections (UTI), respira-
tory tract infections (RTI) and wound infections (WI), 
were selected to describe prescription habits of veteri-
narians and their accordance with national and interna-
tional prudent use recommendations.7–9 28
MateRIals and Methods
study design
The study was designed as a retrospective multicentre 
study involving two university teaching hospitals with 
annual caseloads of 6000 and 12,000 cases, respectively, 
and 14 private practices across Switzerland ranging from 
one- vet mixed practices to middle- sized small animal 
clinics. It also included one very large private clinic with 
over 80,000 cases per year. Antimicrobial prescriptions 
were assessed for selected diseases in both dogs and cats 
using the same study design. The results in cats have 
recently been published.24
data collection
Electronic medical records were screened via full- text 
searches for eligible patients using predefined search 
terms (table 1). Dogs with AD, proven or suspected UTI, 
proven or suspected RTI and WI were included if they 
met the inclusion criteria outlined in table 1. Data collec-
tion was performed as previously described.24 Briefly, 
private practices using either OblonData (Amacker & 
Partner Informatik AG, Switzerland) or Diana SUISSE 
(Diana Software AG, Switzerland) practice management 
software were included.
The sample size for private practices was calculated to 
estimate the prevalence of treatment according to guide-
lines, corresponding to a justification score of 1 (JS-1) 
with a precision of ±8 per cent, assuming a prevalence of 
50 per cent, a confidence level of 95 per cent and a popu-
lation size of 550,000 registered dogs in Switzerland.29 
The sample size of 151 cases per indication, which was 
determined with the Epitools online calculator (https:// 
epitools. ausvet. io/ site/ samplesize), was rounded up to a 
target sample size of 160. To avoid over- represention of 
large practices, we limited the number of cases per prac-
tice to 16 (10 per cent of the target sample size), which 
were randomly selected via the sampling function in 
Excel. For the university clinics, all available cases were 
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included in order to get close to the target sample size of 
160 cases per indication.
Due to the relatively rare occurrence of uncomplicated 
abscesses and WI at university teaching hospitals, this indi-
cation was only assessed in cases from private practices. 
Signalment, vaccination status, clinical history, clinical 
examination, treatment with antimicrobials within seven 
days before presentation, diagnostic work- up, comorbid-
ities as well as hospitalisation length were recorded in 
addition to parameters relating to antimicrobial therapy 
including class, dosage, frequency of application and 
duration of therapy. In dogs with several problems, anti-
microbial prescriptions were not recorded, if it was clear 
that they were given to treat coinfection of a different 
organ system.
Animals, which were presented again for the same 
problem, were only included once.
definitions
Minimal diagnostic work- up was defined as a complete 
blood count (CBC) for AD, urinary sediment examina-
tion for UTI and a CBC and at least one thoracic radio-
graphic view for RTI.
Bacteriuria was defined as the presence of bacteria in 
sediment analysis or in bacterial culture from an asepti-
cally collected urine sample (cystocentesis). Complicated 
UTI was defined according to previous guidelines as infec-
tion in the presence of anatomical or functional changes 
or disorders of the immune system, recurrent UTI 
(three times per year or more) and UTI in non- castrated 
males.28 These guidelines, which were published in 2011, 
have since been substantially revised. The revised guide-
lines have been published in 2019.30
Sepsis criteria were considered fulfilled if dogs showed 
lethargy in addition to at least one of the following criteria 
proposed by Hauptman and others31: body temperature 
>39.4°C, heart rate >140/min, white blood cell (WBC) 
<4 or >25×109/l and banded neutrophils >1.5×109/l.
Cases of RTI were categorised as severe if the dogs 
fulfilled above- mentioned sepsis criteria in addition to 
signs of pulmonary involvement, either by auscultation 
(crackles) or on at least one lateral thoracic radiograph. A 
more detailed severity score could not be applied because 
relevant data were commonly missing from the medical 
records. For the same reason, the severity of disease was 
not assessed in the remaining three indications.
In accordance with WHO guidelines,32 highest priority 
critically important antimicrobials (HPCIAs) were 
defined as third- generation or fourth- generation ceph-
alosporins, quinolones, macrolides, ketolides, glycopep-
tides and polymyxins. Combination therapy was defined 
as the prescription of two or more antibiotic classes at the 
same time.
Justification score
Antimicrobial prescriptions were compared with the 
recommendations summarised in table 2, which were 
based on existing consensus national and international 
guidelines.7–9 28 A previously published justification score 
(JS-1 to JS-4)33 was used with modifications to evaluate 
the appropriateness of the prescription in all cases where 
sufficient clinical information was available (table 3).
For the duration and dosage, ±1 day and up to ±20 per 
cent deviations were accepted.
Statistical analysis
Data were evaluated using a commercial statistical soft-
ware package (NCSS11 Statistical Software (2016)  ncss. 
com/ software/ ncss). Descriptive statistics were used for 
patient characteristics including sex, age and prescribed 
antimicrobials (table 4). Shapiro- Wilk testing revealed 
non- normal distribution for age, weight and duration 
of treatment (in each category), which were therefore 
reported as median and IQR. Patient characteristics, anti-
microbial pretreatments, differences in diagnostic work- 
up, antibiotic classes, the use of HPCIAs and duration 
of therapy were recorded and compared between dogs 
presented to university hospitals and private practices 
using the chi- squared test or Fisher’s exact test when the 
expected value in a cell was <5 for categorical and the 
Mann- Whitney test for continuous variables. The Bonfer-
roni method was applied to correct the significance levels 
for multiple comparisons.
Risk factors for the unfavourable JS-3 and JS-4 and for 
the prescription of HPCIAs were identified using univar-
iate logistic regression analysis. The following potential 
risk factors were assessed: presence of haemorrhagic 
diarrhoea, presence of leucopenia or leukocytosis and 
the presence of a left- shift for AD; complicated UTI, non- 
castrated male status and urinary catheterisation for UTI; 
and duration of clinical signs ≤7 days, lacking or not up 
to date vaccinations, lack of minimal work- up, hospital-
isation and presence of a left shift for RTI. Finally, for 
WI, age less than three years, hospitalisation, local treat-
ment of the wound and presence of a left shift were 
examined. All other associations were studied using the 
chi- squared test. Multivariable logistic regression anal-
ysis was attempted, but due to the low number of dogs 
in each category for which detailed clinical information 
was available, no relevant associations could be identi-
fied. Results are reported as per cent with 95 per cent 
CIs where appropriate or as ORs with 95 per cent CIs. 
Significance was set at P<0.05 for all tests apart from the 
post hoc multiple comparisons.
Results
Case characteristics
A total of 1065 dogs were included in the study, 343 
of which were presented at university hospitals and 
722 at private practices. Case characteristics are shown 
in table 4. Age and sex were not significantly different 
between the dogs seen at university hospitals and those 
seen at private practices. Dogs presented to a university 
hospital were significantly more likely to be pretreated 
with antimicrobials (24 per cent, 95 per cent CI 0.19 per 
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Table 2 Criteria used to judge appropriate use of antimicrobials based on national and international recommendations7–9 28
Indication Comment Antimicrobial
Dosage 
(mg/kg)
Application 
frequency
Treatment duration 
(days)
Acute 
diarrhoea
Antimicrobial therapy NOT indicated unless clinical 
suspicion of sepsis based on clinical and laboratory 
data.*7–9
Ampicillin 20 Twice daily/three 
times a day
5–7
Amoxicillin 11–15 Twice daily/three 
times a day
5–7
Amoxicillin/clavulanic acid 12.5–20 Twice daily/three 
times a day
5–7
Ampicillin/sulbactam‡ 30 Twice daily/three 
times a day
5–7
If suspicion of sepsis* and no improvement with 
initial therapy after two to three days, antimicrobial 
spectrum may be extended by adding.7–9
Enrofloxacin OR 10–20 Once daily 5–7
Marbofloxacin AND/OR 2 Once daily 5–7
Metronidazole 15 Twice daily 5–7
UTIs According to 2011 guidelines, complicated UTIs 
are defined as infections caused by anatomical 
or functional changes or disorders of the immune 
system, recurrent UTI /three times per year or more) 
or UTI in non- castrated male.28
Sporadic (uncomplicated) UTI       
Amoxicillin 11 ̶ 15 Twice daily/three 
times a day
5 ̶ 7
Ampicillin† 20 Twice daily/three 
times a day
5–7
Complicated UTI       
Amoxicillin 11–15 Twice daily/three 
times a day
5–28
Amoxicillin/clavulanic acid 12.5–20 Twice daily/three 
times a day
5–28
Ampicillin† 2020 Twice daily/three 
times a day
5–28
Ampicillin/sulbactam‡ 30 Twice daily/ 5–28
Trimethoprim/sulfadiazin 15 Twice daily 5–28
Trimethoprim/sulfamethoxazole 15 Twice daily 5–28
Non- castrated male dogs   Once daily   
Enrofloxacin 10–20 Once daily 5–42
Marbofloxacin 2 Twice daily 5–42
Trimethoprim/sulfadiazin 15 Twice daily 5–28
Trimethoprim/sulfamethoxazole 15   5–28
Respiratory 
tract 
infections
Aspiration pneumonia or bacterial 
bronchopneumonia.7–9
Mild to moderate disease     Treatment 1 week beyond 
resolution of clinical/
radiographic signs
Doxycycline 10 Once daily
Amoxicillin/clavulanic acid 12.5–20 Twice daily/three 
times a day
Ampicillin/sulbactam‡ 30 Twice daily/three 
times a day
Severe cases     
Amoxicillin/clavulanic acid OR 12.5–20 Twice daily/three 
times a day
Ampicillin/sulbactam‡ 30 Twice daily/three 
times a day
AND     
Enrofloxacin OR 10–20 Once daily
Marbofloxacin 2 Once daily
Kennel cough: antimicrobial therapy only indicated 
if: poor general condition, rectal T>39.4°C or signs 
of lower airway involvement.7–9
Doxycycline 10 Once daily 5–14
Continued
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Indication Comment Antimicrobial
Dosage 
(mg/kg)
Application 
frequency
Treatment duration 
(days)
Wound 
infections
Bite wounds: antimicrobial therapy always indicated, 
except damage limited to epidermis.
Abscesses: antimicrobial therapy only indicated 
if fever, reduced general demeanour, very 
contaminated wound or proximity to fragile tissues 
(ie, joints).7–9
  Amoxicillin/clavulanic acid   12.5–20   Abscesses or superficial¶ bite 
wounds: 5–7.Twice daily
Cefalexin 20–35 Twice daily/three 
times a day
Deep** or penetrating bite 
wounds: 7–10.
Clindamycin 10–15 Twice daily
*Sepsis criteria used: lethargy plus at least one of the following: body temperature >39.4°C, heart rate >140/min, WBC <4 or >25×109/l and banded 
neutrophils >1.5×109/l.
†Intravenous or subcutaneous.
‡Intravenous.
§Severe clinical, laboratory or radiographic signs.
¶Only skin damaged.
**Skin and deeper structures damaged.
UTI, urinary tract infection.
Table 2 Continued
Table 3 Modified justification score used to judge the 
accordance of antimicrobial prescriptions in dogs33
Justification 
score Criteria
JS-1 Empirical treatment in accordance with national 
and international recommendations, that is, correct 
indication, antimicrobial class, dosage and treatment 
duration
OR correct treatment according to culture and 
sensitivity profile
OR no antibiotic needed and none prescribed.
JS-2 Wrong dosage and/or duration of treatment.
JS-3 Wrong antimicrobial class.
JS-4 Decision to treat NOT in accordance with guidelines, 
that is, antibiotic prescription when not indicated or 
no antibiotic prescription although indicated.
cent to 0.28 per cent vs 2 per cent, 95 per cent CI 0.01 
per cent to 0.04 per cent; P<0.001) and were significantly 
more frequently hospitalised (250/343; 73 per cent, 95 
per cent CI 0.68 per cent to 0.78 per cent) compared with 
private practice (29/722; 4 per cent, 95 per cent CI 0.03 
per cent to 0.06 per cent; P<0.001).
antimicrobial prescription overall
In total, 786 (74 per cent) dogs received antimicrobials 
either as monotherapy (94 per cent) or combination 
therapy (6 per cent). The most used antimicrobials were 
potentiated aminopenicillins (59 per cent), followed by 
nitroimidazoles (22 per cent), non- potentiated amin-
openicillins (16 per cent), fluoroquinolones (13 per 
cent), tetracyclines (5 per cent), first- generation (4 per 
cent) and third- generation cephalosporins (2 per cent). 
The proportion of dogs receiving combination therapy 
was significantly higher at university hospitals (34/343; 13 
per cent, 95 per cent CI 0.07 per cent to 0.14) compared 
with private practices (13/520; 3 per cent, 95 per cent CI 
0.01 per cent to 0.04 per cent; P<0.001).
There was no difference in the frequency of prescrip-
tion of HPCIAs between university hospitals and private 
practices. Non- potentiated aminopenicillins were 
prescribed significantly more commonly in private prac-
tices (16 per cent, 95 per cent CI 0.14 per cent to 0.19 per 
cent) compared with university hospitals (3 per cent, 95 
per cent CI 0.01 per cent to 0.04 per cent; P<0.001).
At university hospitals, a significantly higher propor-
tion of prescriptions were in complete accordance (JS-1 
48 per cent, 95 per cent CI 0.42 per cent to 0.53 per cent 
vs 34 per cent, 95 per cent CI 0.30 per cent to 0.37 per 
cent; P<0.001) or complete discordance (JS-4 35 per 
cent, 95 per cent CI 0.30 per cent to 0.40 per cent vs 28 
per cent, 95 per cent CI 0.25 per cent to 0.31 per cent; 
P=0.02) with consensus guidelines compared with private 
practices. A significantly higher proportion of dogs at 
university hospitals was treated with an antimicrobial 
class not recommended in guidelines compared with 
private practice (JS-3 13 per cent,95 per cent CI 0.09 per 
cent to 0.17 per cent vs 5 per cent, 95 per cent CI 0.04 
per cent to 0.07 per cent; P<0.001). The proportions of 
dogs receiving an incorrect dosage or treatment duration 
(JS-2) was not significantly different between university 
hospitals and private practices (3 per cent, 95 per cent CI 
0.01 per cent to 0.05 per cent vs 4 per cent, 95 CI per cent 
0.03 per cent to 0.06 per cent; P=0.3).
No differences were found between the two university 
hospitals regarding the prescription of HPCIAs (P=0.3), 
of fluoroquinolones (P=0.2) or the use of combination 
therapy (P=0.5). Moreover, there was no significant 
difference in the number of cases in agreement (P=0.5) 
or disagreement (P=0.6) with the guidelines. The only 
significant difference between the two university hospi-
tals was in the number of hospitalised patients (86 per 
cent, 95 per cent CI 0.79 per cent to 0.92 per cent vs 65 
per cent, 95 per cent CI 0.58 per cent to 0.71 per cent; 
P<0.001).
antimicrobial prescriptions for ad
Numbers and proportions of diagnostic procedures, anti-
microbial prescriptions and justification scores for dogs 
with AD are shown in table 5.
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Table 5 Diagnostic work- up and antibiotic prescriptions 
in 371 cases of canine acute diarrhoea cases presented to 
university hospitals or private practices
Parameter
University 
hospitals
Private 
practices P value*
Total number of cases 165 206
Minimal diagnostic work- up, n (%)†
  Yes 131 (79) 12 (6) <0.001
  No 34 (20) 194 (94)
Sepsis criteria fulfilled, n 
(%)‡
  Yes 34 (21) 21 (10) 0.08
  No 129 (78) 134 (65)
  Unknown 2 (1) 51 (25)
Haemorrhagic diarrhoea, 
n (%)
  Yes 101 (61) 52 (25) <0.001
  No 64 (39) 132 (64)
  Unknown 0 (0) 22 (11)
Hospitalisation, n (%)
  Yes 141 (85) 9 (4) <0.001
  No 24 (15) 197 (96)
Pretreated, n (%)
  Yes 24 (15) 0 (0) <0.001
  No 138 (84) 194 (94)
  Unknown 3 (1) 12 (6)
Antibiotic therapy, n (%)
  Yes 116 (70) 127 (62) 0.08
Antibiotic classes, n (%)
  Potentiated 
aminopenicillins
55 (47) 13 (10) <0.001
  Nitroimidazole 74 (64) 100 (79) 0.5
  Non- potentiated 
aminopenicillins
0 (0) 9 (6) 0.007
  Third- generation 
cephalosporins
0 (0) 3 (2) 0.1
  Tetracyclines 0 (0) 3 (2) 0.1
  Fluoroquinolones 3 (3) 15 (12) 0.01
Combination therapy, n (%)
  Yes 11 (9) 6 (5) 0.1
  No 105 (91) 121 (95)
HPCIA, n (%)§
  Yes 3 (3) 18 (14) 0.004
  No 113 (97) 109 (86)
Duration of therapy (days)
  Median (IQR) 8 (7–9) 6 (5–7) <0.001
Justification score, n (%)
  1 57 (35) 62 (30) 0.4
  2 5 (3) 0 (0) 0.01
Continued
Parameter
University 
hospitals
Private 
practices P value*
  3 15 (9) 3 (1) <0.001
  4 88 (53) 102 (50) 0.5
  Judgement not possible 1 (0.6) 39 (19)
*Statistically significant P values after Bonferroni correction are 
written in bold characters.
†Minimal work- up is CBC.
‡Criteria fulfilled if lethargic and at least one of the following: body 
temperature >39.4°C, heart rate >140/min, WBC <4 or >25×109/l 
and band neutrophils >1.5×109/l.
§HPCIA: highest priority critically important antimicrobials include 
third- generation or higher generation cephalosporins, quinolones, 
macrolides, ketolides, glycopeptides and polymyxins.
CBC, complete blood count; WBC, white blood cell.
Table 5 Continued
Of the 371 dogs presented for AD, 243 (65 per cent) 
received antimicrobial therapy with the following classes: 
nitroimidazoles (72 per cent), potentiated aminopen-
icillins (28 per cent), fluoroquinolones (7 per cent), 
non- potentiated aminopenicillins (4 per cent), third- 
generation cephalosporins (1 per cent) and tetracyclines 
(1 per cent). Combination therapy was prescribed in 7 
per cent of the cases and was associated with the presence 
of sepsis criteria.31 Twenty- one dogs (8 per cent) received 
a least one HPCIA. The use of HPCIAs was not associated 
with the presence of sepsis criteria. The duration of the 
treatment was significantly longer at university hospitals 
compared with private practices.
A total of 143 dogs (39 per cent) underwent minimal 
diagnostic work- up (CBC) and 84 dogs (23 per cent) had 
a coprological examination performed. Giardia species 
was detected in 10/84 dogs and 7 of them received 
metronidazole.
Dogs presenting at university hospitals had significantly 
more haemorrhagic diarrhoea than those presenting at 
private practices (P<0.001). The presence of haemor-
rhagic diarrhoea was significantly associated with the use 
of antibiotics (P<0.001) and hospitalisation (P<0.001) but 
not with the presence of sepsis criteria (P=0.08). Univar-
iate logistic regression analysis also showed that the odds 
for an incorrect utilisation of antimicrobials (JS-4) was 
2.26 times higher in dogs with haemorrhagic diarrhoea 
(95 per cent CI 1.46 to 3.51; P<0.001).
Subgroup analysis of 55 dogs for which criteria of sepsis 
were fulfilled showed no significant difference regarding 
the overall antimicrobial prescription rate (P=0.1) nor 
the prescription of HPCIAs (P=0.05) between univer-
sity hospitals and private practices. However, there were 
significantly more cases in total disagreement with the 
guidelines at private practices (62 per cent) than at 
university hospitals (9 per cent; P<0.001).
When looking at the subgroup of 153 dogs with haem-
orrhagic diarrhoea, there was no significant difference 
between university hospitals and private practices with 
regards to the overall antimicrobial prescription rate 
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Table 6 Diagnostic work- up and antibiotic prescriptions 
in 245 dogs with suspected UTIs presented to university 
hospitals or private practices
Parameter
University 
hospital
Private 
practice P value*
Number of cases 70 175
Microscopic sediment analysis, n (%)
  Yes 59 (84) 73 (42) <0.001
  No 11 (16) 81 (46)
Bacterial culture, n (%)
  Yes 67 (96) 43 (25) <0.001
  No 3 (4) 132 (75)
UTI considered complicated, n 
(%)*†
  Yes 48 (69) 46 (26) <0.001
Bacteriuria, n (%)†‡
  Confirmed 62 (88) 27 (15) <0.001
  Excluded 7 (10) 22 (13)
  No enough data to confirm or 
exclude bacterial aetiology
1 (2) 126 (72)
Hospitalisation, n (%)
  Yes 40 (56) 5 (3) <0.001
  No 30 (44) 170 (97)
Pretreated, n (%)
  Yes 14 (20) 6 (3) <0.001
  No 54 (77) 162 (93)
  Unknown 2 (3) 7 (4)
Antibiotic therapy
  Yes 68 (97) 147 (84) 0.3
  No 2 (3) 28 (16)
Antibiotic classes, n (%)
  Potentiated aminopenicillins 53 (78) 97 (65) 0.07
  Fluoroquinolones 12 (17) 43 (29) 0.07
  Non- potentiated 
aminopenicillins
5 (7) 22 (15) 0.2
  First- generation 
cephalosporins
2 (3) 11 (7) 0.2
  Third- generation 
cephalosporins
0 (0) 3 (2) 0.2
  Lincosamide 2 (3) 0 (0) 0.02
  Amphenicols 1 (1) 0 (0) 0.1
  Potentiated sulfonamides 1 (1) 0 (0) 0.1
Combination therapy, n (%)
  Yes 5 (7) 0 (0) <0.001
  No 63 (93) 147 (100)
HPCIA‡§
  Yes 11 (16) 47 (32) 0.03
  No 57 (84) 100 (68)
Duration of therapy (days)
  Median (IQR) 18 (10–27) 11 (7–14) <0.001
Continued
(P=0.6) and the prescription of HPCIAs (P=0.08) as 
well the number of prescriptions in complete agree-
ment (P=0.9) or complete disagreement (P=0.3) with 
consensus guidelines.
When looking at the subgroup of 160 dogs with AD 
that were hospitalised, there was no statistical differ-
ence between university hospitals and private practices 
regarding the overall antimicrobial prescription rate. 
However, HPCIAs were more frequently used at private 
practices (16 per cent) than at university hospitals (2 per 
cent, P=0.003). A significantly higher proportion of cases 
was judged in total agreement (33 per cent vs 5 per cent; 
P=0.01) and a significantly lower proportion in complete 
disagreement (53 per cent vs 84 per cent; P=0.01) with 
guidelines at university hospitals than at private practices.
Agreement with consensus guidelines could be eval-
uated in 89 per cent (331/371) of dogs with AD. In 
these dogs, treatment was in total compliance with the 
consensus guidelines (JS-1) in 36 per cent of the cases and 
in total disagreement in 57 per cent of dogs (JS-4). For 18 
(5 per cent) cases, the chosen antimicrobial class was not 
in agreement with the consensus guidelines (JS-3). In the 
majority of these cases (17/18), metronidazole was used 
instead of or in combination with the recommended 
potentiated aminopenicillins. The dogs with a JS-4 score 
were either treated when not needed (187/190; 98 per 
cent) or not treated when needed (3/190; 2 per cent).
antimicrobial prescription for utI
Numbers and proportions of diagnostic procedures, anti-
microbial prescriptions and justification scores for UTI 
are shown in table 6. Antimicrobials were prescribed in 
215/245 dogs (88 per cent) with suspected or proven UTI. 
The following antimicrobials were prescribed as either 
monotherapy (98 per cent) or combination therapy (2 
per cent): potentiated aminopenicillins (61 per cent), 
fluoroquinolones (22 per cent), non- potentiated amin-
openicillins (11 per cent), first- generation cephalo-
sporins (5 per cent), third- generation cephalosporins 
(1 per cent), lincosamides (0.8 per cent), amphenicoles 
(0.4 per cent) and potentiated sulfonamides (0.4 per 
cent). All five dogs receiving combination therapy had 
urinary culture and antimicrobial susceptibility testing 
performed, demonstrating infection with MDROs in 
three and the presence of two different bacteria with 
different resistance profiles in two dogs.
The most frequently employed HPCIAs were fluoro-
quinolones, and their use was not associated with a non- 
castrated male status (P=0.3). There was a borderline 
association between the presence of MDROs in urine and 
the use of HPCIAs (P=0.06).
Diagnostic work- up (microscopic sediment analysis or 
culture) was significantly more commonly performed at 
university hospitals compared with private practices. Of 
all dogs receiving antimicrobials, 85 (40 per cent) had a 
confirmed bacterial aetiology.
In 50 per cent of the total cases, a justification score 
could not be attributed because of a lack of data and/or 
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Parameter
University 
hospital
Private 
practice P value*
Justification score, n (%)
  1 38 (54) 11 (6) <0.001
  2 4 (6) 1 (0.5) 0.01
  3 13 (19) 17 (10) 0.06
  4 14 (20) 25 (14) 0.3
  Judgement not possible 1 (1) 121 (69)
*Statistically significant P values after Bonferroni correction are 
written in bold characters
†Complicated UTI defined according to previous guidelines as 
infections in the presence of anatomical or functional changes 
or disorders of the immune system, recurrent UTI (three times 
per year or more) and UTI in non- castrated males.28
‡Defined as either positive microscopic sediment analysis or 
positive bacterial culture.
§HPCIA: highest priority critically important antimicrobials 
include third- generation or higher generation cephalosporins, 
quinolones, macrolides, ketolides, glycopeptides and 
polymyxins.
UTI, urinary tract infection.
Table 6 Continued Table 7 Diagnostic work- up and antibiotic prescriptions 
in 274 dogs with respiratory tract infections presented to 
university hospitals or private practices
Parameter
University 
hospital
Private 
practice P value*
Number of cases 108 166
Duration of clinical signs, n (%)
  <7 days 49 (45) 49 (30) 0.03
  >7 days 34 (31) 15 (9)
  Unknown 25 (23) 102 (61)
Minimal work- up, n (%)†
  Yes 75 (69) 1 (0.6) <0.001
Broncho- alveolar lavage and 
culture, n (%)
  Yes 8 (7) 2 (1) 0.007
Cases judged severe, n (%)‡
  Yes 25 (24) 1 (0.6) 0.7
  No 3 (3) 0 (0)
  Impossible to judge 80 (73) 165 (99.4)
Diagnosis based on clinical signs 
in addition to, n (%)
  Clinical examination alone 15 (14) 145 (87) <0.001
  Clinical examination and 
radiographs
72 (66) 16 (10) <0.001
  Clinical examination, 
radiographs (optional) and 
bronchoscopy
12 (11) 6 (4) 0.014
  Clinical examination, 
radiographs (optional), 
bronchoscopy and BAL
8 (7) 2 (1) 0.007
Hospitalisation, n (%)
  Yes 69 (54) 1 (0.6) <0.001
  No 39 (36) 165 (99.4)
Pretreated, n (%)
  Yes 41 (37) 7 (4) <0.001
  No 66 (62) 158 (95.4)
  Unknown 1 (1) 1 (0.6)
Antibiotic therapy, n (%)
  Yes 82 (76) 89 (49) <0.001
  No 26 (24) 77 (51)
Antibiotic classes, n (%)
  Potentiated aminopenicillins 59 (71) 58 (65) 0.3
  Tetracyclines 12 (15) 26 (29) 0.03
  Non- potentiated 
aminopenicillins
2 (2) 33 (37) <0.001
  Fluoroquinolones 23 (28) 4 (4) <0.001
  First- generation 
cephalosporins
4 (5) 0 (0) <0.001
  Third- generation 
cephalosporins
1 (1) 3 (3) 0.4
Combination therapy, n (%)
  Yes 18 (22) 4 (5) <0.001
  No 64 (88) 85 (95)
Continued
diagnostic work- up. Of all dogs for which a justification 
score could be given, complete accordance to the guide-
lines (JS-1) was observed in 49 dogs (20 per cent) and 
significantly more often at university hospitals compared 
with private practices (54 per cent vs 6 per cent; P<0.001). 
In 24 per cent of the dogs an inappropriate antimicro-
bial was prescribed (JS-3). In most of the cases, potenti-
ated aminopenicillins were chosen as first- line treatment 
instead of non- potentiated aminopenicillins. The dogs 
with a JS-4 score were either treated when not needed 
(37/39; 95 per cent) or not treated when needed (2/39; 
5 per cent).
antimicrobial prescription for RtI
Numbers and proportions of diagnostic procedures, 
antimicrobial prescriptions and justification scores for 
RTI are shown in table 7. Of the 274 dogs, which were 
treated for suspected of confirmed RTI, 171 (62 per 
cent) received monotherapy or combination antimicro-
bial therapy of the following classes: potentiated amin-
openicillins (43 per cent), tetracyclines (14 per cent), 
non- potentiated aminopenicillins (12 per cent), fluoro-
quinolones (10 per cent), first- generation (1 per cent) 
and third- generation cephalosporins (1 per cent). The 
use of HPCIAs and the prescription of combination 
therapies were significantly more frequent at university 
hospitals (P<0.001). The use of combination therapy was 
not associated with cases categorised as severe (P=0.07). 
Minimal work- up (CBC and thoracic radiographs) was 
more commonly performed at university hospitals (69 
per cent vs 0.9 per cent; P<0.001). A diagnosis of aspira-
tion pneumonia was made in 42 dogs (15 per cent) and 
28 (10 per cent) dogs were diagnosed with kennel cough. 
In 13 dogs (5 per cent), a diagnosis of bronchitis resulted 
from radiography and also sometimes endoscopy, 3 dogs 
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Parameter
University 
hospital
Private 
practice P value*
HPCIA§
  Yes 25 (30) 7 (8) <0.001
  No 57 (70) 82 (92)
Duration of therapy (days)
  Median (IQR) 12.7 (3–20) 6.3 (0–10) <0.001
Justification score, n (%)
  1 68 (63) 64 (39) <0.001
  2 1 (1) 3 (2) 0.6
  3 15 (14) 11 (7) 0.04
  4 19 (18) 45 (27) 0.06
  Judgement not possible 5 (5) 43 (26) <0.001
*Statistically significant P values after Bonferroni correction are written 
in bold characters.
†Minimal work- up consist of a thoracic radiograph and CBC.
‡Cases were judged as severe if there was a reduced general 
state+signs of SIRS (systemic inflammatory response syndrome)/
sepis/left- shift+pulmonary involvement (radiographs or auscultation).
§HPCIA: highest priority critically important antimicrobials include 
third- generation or higher generation cephalosporins, quinolones, 
macrolides, ketolides, glycopeptides and polymyxins.
BAL, broncho- alveolar lavage; CBC, complete blood count.
Table 7 Continued Table 8 Presence of clinical signs and antibiotic 
prescription in 175 dogs with wound infections presented to 
private practices
Parameter
Private practice, 
n (%)
Number of cases
  175
Type of lesion
  Abscess 40 (23)
  Bite 135 (77)
Local wound treatment
  Yes 113 (65)
  No 14 (8)
  Unknown 48 (27)
Drain placed
  Yes 14 (8)
  No 161 (92)
Antibiotic therapy
  Yes 157 (90)
  No 18 (10)
Antibiotic classes
  Potentiated aminopenicillins 132 (75)
  Non- potentiated aminopenicillins 54 (31)
  First- generation cephalosporins 18 (10)
  Fluoroquinolones 5 (3)
  Third- generation cephalosporins 2 (1)
  Lincosamide 1 (0.5)
  Penicillins 0 (0)
Combination therapy
  Yes 3 (2)
HPCIA*
  Yes 7 (4)
  Duration of therapy: days (IQR) 7.6 (5.9–10)
Justification score
  1 105 (60)
  2 26 (15)
  3 6 (3)
  4 28 (16)
  Judgement not possible 10 (6)
*HPCIA: highest priority critically important antimicrobials 
include third- generation or higher generation cephalosporins, 
quinolones, macrolides, ketolides, glycopeptides and 
polymyxins.
(0.1 per cent) were diagnosed with pneumonia based on 
consistent radiographic changes, 3 dogs (0.1 per cent) 
with eosinophilic bronchopathy and 1 dog (0.03 per 
cent) with distemper. The remaining cases (183 dogs, 67 
per cent) were classified as ‘unknown’ in the absence of 
a definitive diagnosis. Those cases were more frequently 
seen at private practices (150/183; P<0.001).
Agreement with consensus guidelines could be evalu-
ated in 82 per cent (226/274) of dogs with RTI. Of all 
dogs for which a justification score could be given, 132 
cases (58 per cent) were managed according to the 
guidelines (JS-1). There were significantly more cases 
with a justification score JS-1 among the university hospi-
tals than private practices (63 per cent vs 39 per cent; 
P<0.001). A total of 93 (42 per cent) cases were not 
treated in agreement with the guidelines for prudent 
antimicrobial prescription (JS-2; 3, 1 per cent; JS-3: 26, 
13 per cent; JS-4: 64, 28 per cent). The dogs with a JS-4 
score were either treated when not needed (62/64; 97 
per cent) or not treated when needed (2/64; 3 per cent).
antibiotic prescription for abscesses and bite wounds (WI)
Numbers and proportions of diagnostic procedures, anti-
microbial prescriptions and justification scores are shown 
in table 8. Of the 175 dogs treated for abscesses or bite 
wounds at private practices, 157 (90 per cent) received 
monotherapy or combination antimicrobial therapy.
Forty per cent of dogs presented for abscess (16/40) 
had at least one clinical sign listed in the guidelines 
(fever, lethargy, severely contaminated wound or prox-
imity to fragile tissues) justifying systemic antimicrobial 
treatment. Thirty per cent of those presented for bite 
wounds had at least one clinical sign listed in the guide-
lines (bite wound penetrating the epidermis), justifying 
antimicrobial use. Data were not enough for a judgement 
in 10 cases (6 per cent). A total of 105 cases (64 per cent) 
were treated in complete accordance with guidelines 
(JS-1), whereas 60 (36 per cent) were not (JS-2: 26, 16 per 
cent; JS-3: 6, 4 per cent; JS-4: 28, 17 per cent). The dogs 
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with a JS-4 score were either treated when not needed 
(15/28; 54 per cent) or not treated when needed (13/28; 
46 per cent). Dogs not treated when needed were in the 
vast majority (12/13) dogs with bite wounds.
dIsCussIon
The results of this study demonstrate that there is ample 
room for improvement regarding the prudent use of 
antimicrobials in Switzerland, as inappropriate prescrip-
tions were common for dogs with AD, UTI, RTI and WI. 
Indeed, in 41 per cent of cases, antimicrobial treatment 
was in partial or complete disagreement with national 
and international guidelines. These findings concur 
with studies in human and veterinary medicine showing 
that antimicrobials are commonly prescribed without 
clear indication,10 11 13 16 18 19 21 34 35 that HPCIAs are used 
as first- line agents12 15 23 and that adherence to general 
guidelines is often poor, both in hospital10 21 36 37 and first 
opinion practice settings.12 16 38 The results also concur 
with the situation in selected feline conditions in Swit-
zerland where 38 per cent of antimicrobial treatments 
were found to be in in partial or total disagreement with 
consensus guidelines. In that study HPCIAs, in particular 
third- generation cephalosporins, were used as first- line 
treatment in up to 20 per cent of cases.24 Possible reasons 
for the high rate of inappropriate antimicrobial prescrip-
tions in Switzerland in 2016 likely include the absence of 
national guidelines before the introduction of  Antibiot-
icScout. ch and a lack of emphasis on prudent antimicro-
bial use in the veterinary curriculum.
The challenges and reasons for poor adherence to 
prudent use recommendations likely vary consider-
ably between referral and first opinion practices as 
patient populations and owner expectations may be very 
different.36 39–41 In this cohort of dogs, pretreatment 
with antimicrobials was significantly more common in 
dogs presented to university hospitals, where the diag-
nostic work- ups were generally more complete, a higher 
proportion of patients were hospitalised, had more 
severe disease and received a combination of antimicro-
bials. All these factors are consistent with a referral popu-
lation, which may be characterised by more complex 
illness and owners more willing to pursue further diag-
nostics. However, owner expectations for antimicrobial 
treatment after minimal diagnostic work- up has been 
reported as one of the barriers to prudent antimicrobial 
use in first opinion practice.39–42 Moreover, expertise of 
the staff, access to diagnostic tools and the existence and 
level of implementation of local policies for the use of 
antimicrobials may also vary between university hospitals 
and private practices.
Regarding the overall choice of antimicrobials across all 
four selected disease groups, aminopenicillins were the 
most commonly prescribed antimicrobials, which is also 
reflected by the national sales figures43 and concurs with 
reports from other countries.12 16 18 44 Third- generation 
cephalosporins were rarely used in this cohort of dogs, 
which is in contrast to data from cats in Switzerland 
and elsewhere.23 24 45 46 Cefovecin is the only long- acting 
injectable third- generation cephalosporin registered for 
use in dogs and cats in Switzerland at present. Cefovecin 
is licenced to treat infections of skin, soft tissues, gingiva 
and urinary tract in dogs and cats. The rare use of third- 
generation cephalosporins in this cohort is likely due 
to the choice of indication (ie, skin infections were not 
included) and the fact that it is easier to administer oral 
drugs in dogs than in cats.
When looking at the overall antimicrobial prescriptions, 
no difference was found between the two university hospi-
tals. This could be because similar local antimicrobial 
policies are used. In addition to that, further consensus 
was built while collaborating on the development of the 
guidelines used for the  Antibioticscout. ch online tool26 
and the preparation of this present study during the year 
of 2017.
In this study, two- thirds of dogs with AD received anti-
microbials even though dogs with parvovirosis were 
excluded from the analysis. Current guidelines only 
recommend the use of antimicrobials in dogs with AD 
if clinical or laboratory signs consistent with sepsis are 
present,7–9 but in this cohort, the use of antimicrobials 
was not significantly associated with the presence of 
sepsis. Instead the use of antimicrobials was clearly associ-
ated with the presence of haemorrhagic diarrhoea. These 
results concur with the results of a national retrospective 
study in the UK showing that over 80 per cent of dogs 
with haemorrhagic diarrhoea received antimicrobials 
and often a combination of two antimicrobials.46 This 
reflects the previous belief that haemorrhagic diarrhoea 
is associated with a higher risk of bacterial translocation 
and therefore requires antimicrobial treatment.47 Recent 
evidence however does not support this concept, as dogs 
with acute haemorrhagic diarrhoea syndrome (AHDS) 
were no more likely to have positive blood cultures than 
healthy controls.48 Furthermore, in a prospective placebo 
controlled clinical trial in a population of 60 dogs with 
AHDS, there were no significant differences between 
the group of dogs receiving intravenous amoxicillin- 
clavulanic acid and controls regarding the number of 
hospitalisation days, clinical score and outcome.49 The 
use of antimicrobials should therefore be reserved for 
AD patients with clinical signs of sepsis.
Metronidazole was the most commonly used antimi-
crobial in dogs with AD. Metronidazole and fenbenda-
zole have been used interchangeably in the past to treat 
clinical giardiasis and might have been the reason for 
prescription of metronidazole in some of the dogs even 
though fenbendazole is now the recommended first- 
line treatment.47 Metronidazole is commonly used by 
small animals practitioners, as it is believed to reduce the 
duration of clinical signs and the severity of diarrhoea, 
although evidence is lacking. While nitroimidazoles are 
not classified as critically important antimicrobials in 
Switzerland, their use to treat AD should nevertheless 
be restricted. Metronidazole is used in human medicine 
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for the treatment of often life- threatening Clostridium 
infections, and the number of metronidazole- resistant 
bacterial isolates from animals and humans is rising.50 
Metronidazole may increase the risk of selection of 
multidrug resistant E coli50 51 and possibly favours bacte-
rial translocation.52 Finally, metronidazole can cause a 
potentially severe neurotoxicity in dogs,53–55 as well in 
humans56–59 and should therefore be used cautiously.
Minimal diagnostic work- up was limited to CBC in the 
group of AD, as the presence of neutropenia, neutro-
philia and/or a left- shift are important sepsis criteria.31 
Parasitological examination of faeces was not included 
in the minimal diagnostic work- up, as it was commonly 
replaced by the use of broad- spectrum antiparasitic treat-
ments. Faecal culture and PCR for specific pathogens 
such as Campylobacter spp or Clostridia spp were also not 
considered core elements of the work- up, because there is 
not a clear link between the presence of these pathogens 
in the gut and the occurrence of diarrhoea in dogs.60–62
In the group of dogs with UTI, 88 per cent of dogs 
received antimicrobial treatments, even though a bacte-
rial aetiology was confirmed in only 36 per cent of cases, 
either via sediment analysis or culture. This is consistent 
with results of other national studies.15 63 It is very common 
for patients of first opinion practices with acute signs of 
lower urinary tract disease to receive empirical antimicro-
bial treatment without prior urinalysis and/or culture. In 
a previous questionnaire- based study, only 32.5 per cent 
of companion animal practitioners in Europe reported 
that they frequently undertake antimicrobial susceptibility 
testing when prescribing antimicrobials, whereas 9.1 per 
cent never requested such tests.41 Similarly, in a US study, 
only 38 per cent of dogs with suspicion of UTI receiving 
antimicrobials had a definitive diagnosis of bacterial infec-
tion.10 While in dogs with lower urinary tract signs, bacte-
rial UTIs are more common than in cats, the presence of 
bacteria should nevertheless be confirmed via sediment 
analysis and/or culture before starting antimicrobial 
therapy.28 30 This is emphasised by the fact that around 50 
per cent of urine samples of dogs with clinical signs of UTI 
are sterile on culture.63 64
Similar to previous studies,10 17 63 potentiated amino-
penicillins were used more commonly than non- 
potentiated aminopenicillins to treat sporadic UTI 
in this cohort, although non- potentiated aminope-
nicillins are the recommended choice.26 30 The use 
of non- potentiated aminopenicillins is preferred 
whenever possible, because the addition of clavulanic 
acid increases AmpC- mediated resistance to first- 
generation, second- generation and third- generation 
cephalosporins.65 66 Fluoroquinolones were the second 
most commonly used antimicrobials, and their use was 
associated with, but not restricted to, non- castrated 
males. The use of antimicrobials with good penetra-
tion of the prostate such as fluoroquinolones and 
potentiated sulfonamides has been recommended 
for any UTI in uncastrated dogs in the past.28 Poten-
tiated sulphonamides were only rarely used in this 
cohort. Besides potential unwanted adverse effects 
such as keratoconjunctivitis sicca or hepatitis,67 68 the 
rare use of potentiated sulfonamides in this study 
could be due to the limited availability of this class of 
drugs for companion animals in Switzerland.69 The 
new guidelines for management of UTI issued by the 
International Society for Companion Animal Infectious 
Diseases recommend that the prostate has to be evalu-
ated in non- castrated males with UTI. In the absence of 
evidence of prostatic involvement, it is recommended 
to treat UTI in non- castrated males as a sporadic UTI.30
The vast majority of dogs with suspicion of UTI that 
were not treated in accordance with the guidelines 
were dogs, which received antimicrobial therapy in the 
absence of bacteriuria on sediment analysis or culture. 
The reasons for non- adherence were commonly not clear 
from the medical records. It is imaginable that treatments 
were started empirically and not discontinued when the 
sediment or culture result was received or that clinicians 
disbelieved the results of the sediment analysis but did 
not follow up with culture.
The tendency to selectively gather and interpret 
evidence that confirms a suspected diagnosis but ignore 
the evidences that might disconfirm it (confirmation 
bias) and risk avoidance have been previously discussed 
as important elements, which may lead to incoherence 
between diagnostic test results and clinical decision 
making in patients with UTI.65 Withholding antimicro-
bial therapy, while providing analgesic treatment, in 
patients, which can tolerate this approach until a confir-
matory test result is received, may reduce the number of 
unnecessary treatments of UTI.65
The group of RTI was diverse and included dogs with 
kennel cough, aspiration pneumonia and bronchopneu-
monia. While kennel cough is often a purely clinical diag-
nosis, a diagnosis of aspiration pneumonia is based on a 
consistent history and radiographic pattern, whereas a 
diagnosis of bronchopneumonia should be confirmed via 
cytological and cultural examination of a BAL sample.70 
However, in this cohort, 58 per cent dogs were treated on a 
clinical suspicion of an RTI, and no further diagnostic tests 
were recorded.
At university hospitals, 54 per cent of RTI cases were 
hospitalised and in 24 per cent, the clinical signs were 
judged severe. While this could explain the significantly 
more frequent use of combination therapy and fluoro-
quinolones, it could also give an indication to why rela-
tively few bronchoscopies and/or BAL procedures were 
performed. Indeed, critically ill patients might not be stable 
enough to undergo general anaesthesia, which is required 
for bronchoscopy and/or BAL, and tracheal washes, which 
do not require general anaesthesia, are rarely performed. 
The use of BAL and antimicrobial susceptibility testing is 
however crucial to select the most appropriate antimicro-
bial. A recent study describing sensitivity patterns of bacte-
rial isolates from BAL showed that less than 35 per cent 
of Pseudomonas specie and less than 50 per cent of E coli 
were susceptible to beta- lactam antimicrobials, potentiated 
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sulfonamides or doxycycline, which are commonly used to 
treat canine lower respiratory tract infections.71
While guidelines recommend the use of fluoroquino-
lones only for severe cases of pneumonia with susceptible 
organisms,70 72 combination therapy using aminopenicil-
lins and fluoroquinolones were commonly used as first- line 
treatment in the absence of signs of sepsis in this cohort, 
most likely as a consequence of risk avoidance. In cases 
with kennel cough, aminopenicillins were commonly 
prescribed, even though most cases of kennel cough are 
self- limiting and do not require antimicrobial treatment. If 
kennel cough is associated with a poor general condition, 
fever or signs of lower airway involvement, doxycycline is 
recommended as first- line empirical treatment. Doxycy-
cline is well tolerated by dogs and has good in vitro activity 
against canine isolates of Bordetella bronchiseptica.7–9 70 73
As treatments of uncomplicated wounds and abscesses 
are rare in referral practice, this indication was only assessed 
in private practices. In this study, 90 per cent of the dogs 
presented for abscess or bites were treated with antimicro-
bials, which corresponds to results of other studies, where 
the rate of antimicrobial prescription for abscesses and 
bite wounds was between 90 per cent and 97 per cent.19 46 
According to guidelines, drainage of abscesses is the most 
important treatment, and antimicrobials are indicated for 
bite wounds penetrating the epidermis and for abscesses 
only in case of fever, reduced general status, highly contami-
nated wounds or proximity to fragile tissues.26 74 75 However, 
in this cohort, 90 per cent of dogs with abscesses received 
antimicrobials, while only 39 per cent had an indication. 
These data, therefore, indicate a large potential for reduc-
tion of antimicrobial prescriptions for this indication.
Contrary to other indications, about half of the cases in 
disagreement with guidelines for WI were because of the 
non- prescription of antimicrobial although needed. This is 
in contrast with results from cats in Switzerland and other 
studies.10 12 24
The limitations of the present study include its retrospec-
tive nature and the commonly incomplete documentation 
of cases in the databases, particularly in private practices, 
where information regarding history and clinical signs was 
often not recorded. In this study, practices were only able to 
participate if they were exclusively using practice manage-
ment software for their medical record keeping. While 
vets in Switzerland are obliged to keep medical records, 
the information was sometimes patchy and difficult to 
interpret. Moreover, a selection bias could be present. The 
enrolment of private practices was voluntary, and clinics 
willing to participate may already be using antimicrobials 
more prudently leading to an overestimation of the overall 
adherence to guidelines in the country. Furthermore, the 
manual review of retrospective data by the two evaluators 
(CL and KS) possibly leaves a margin of error and judge-
ment errors cannot be ruled out.
Finally, antimicrobial prescriptions were only assessed 
for four conditions. One important indication for 
antimicrobial prescription in small animal medicine 
is pyodermia.11 12 14 Given that overuse of systemic 
antimicrobials is common for this condition it should be 
included in future studies.37 38
In conclusion, in 2016, antimicrobial prescription for 
selected canine diseases showed a poor agreement with 
national and international guidelines, both at university 
hospitals and private practices. Antimicrobial steward-
ship measures are clearly needed to improve prudent 
use. The impact of the ASP online tool  AntibioticScout. 
ch on prescribing habits of Swiss veterinarians will be 
assessed in a follow- up study.
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